Orphan designation: ganglioside GM1 Treatment of amyotrophic lateral sclerosis, 13/04/2021 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 23 October 2024 - 8:56

Orphan designation: ganglioside GM1 Treatment of amyotrophic lateral sclerosis, 13/04/2021 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-21-2426

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters